Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

Does the -ib medication suffix have meaning? I know -ab medications like Benralizumab, Canakinumab, etc are monoclonal antibodies. The only -ib I can remember other than this new one is Imatinib, which is also a cancer treatment, so maybe it's to do with cancer?
 help



The suffix -ib stands for inhibitor, but it's not a standalone suffix as such.

In this case the "real" suffix is -rasib, meaning RAS inhibitor. This is the "stem" defined by the WHO [1].

You have other suffixes like -coxib (for COX inhibitors like celecoxib) and -nib (for kinase inhibitors like upadacitinib, where -citinib then refers to JAK/TYK type kinase).

Monoclonal antibodies end with -mab, not -ab.

[1] https://www.who.int/teams/health-product-and-policy-standard...


It’s a category called small-molecule drug. I take a medication called upadacitinib for ulcerative colitis. Previously, I took monoclonal antibodies called Ustekinumab and vedolizumab.

These medication-categories are not only prevalent in cancer therapy.

If you look at the molecular size, -ibs are very small and -mabs really huge.


Inhibitor, in this case for the Ras GTPase protein



Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: